All Broad Institute of MIT and Harvard articles
-
NewsScientists ID combination of bacterial strains that could treat antibiotic-resistant gut infections
Researchers have isolated 18 bacterial strains from stool from healthy people that could potentially be an effective treatment for antibiotic-resistant bacterial infections in patients with chronic inflammatory intestinal conditions.
-
NewsStudy links gut microbiome changes to increased risk of type 2 diabetes
Researchers have found that specific species and strains of bacteria are linked to changes in the functioning of the gut microbiome and a person’s risk of type 2 diabetes.
-
NewsSimple test for flu could improve diagnosis and surveillance
A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.
-
NewsScientists link certain gut bacteria to lower heart disease risk
Researchers have identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people.
-
NewsResearchers uncover genetic factors for severe Lassa fever
Researchers have found two key human genetic factors that could help explain why some people develop severe Lassa fever, and a set of LARGE1 variants linked to a reduced chance of getting Lassa fever.
-
NewsScientists shine a new light on the tug-of-war between virus and host
Researchers have recently developed a new method that, for the first time, enables the discovery of interactions for specific regions within a target RNA molecule.
-
NewsCovid-19 protein primes RNA synthesis in human cells
Researchers have shown for the first time that it is the human protein SND1 which works together with the viral protein NSP9 to stimulate the SARS-CoV-2 virus’s genetic replication program in infected cells.
-
NewsCRISPR-like system in eukaryotes can edit the human genome
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
